MERRIMACK PHARMACEUTICALS INC 4

4 · MERRIMACK PHARMACEUTICALS INC · Filed Mar 25, 2015

Form 4

Period: 2015-03-23

DirectorPresident and CEO

Transactions

Sale
Common Stock
2015-03-23$11.69/sh−10,400$121,576→ 1,339,316 total
Exercise/Conversion
Common Stock
2015-03-24$2.59/sh+26,689$69,125→ 1,588,990 total
Exercise/Conversion
Stock Option (right to buy)
2015-03-24−273,968→ 0 total
Exercise: $1.71Exp: 2015-08-03→ Common Stock (273,968 underlying)
Sale
Common Stock
2015-03-24$11.71/sh−103,968$1,217,465→ 1,509,316 total
Exercise/Conversion
Common Stock
2015-03-23$1.71/sh+10,400$17,784→ 1,349,716 total
Exercise/Conversion
Common Stock
2015-03-24$1.71/sh+273,968$468,485→ 1,613,284 total
Exercise/Conversion
Common Stock
2015-03-24$2.12/sh+94,338$199,997→ 1,683,328 total
Exercise/Conversion
Stock Option (right to buy)
2015-03-24−52,985→ 0 total
Exercise: $2.47Exp: 2017-01-23→ Common Stock (52,985 underlying)
Exercise/Conversion
Stock Option (right to buy)
2015-03-24−94,338→ 680,662 total
Exercise: $2.12Exp: 2019-11-05→ Common Stock (94,338 underlying)
Exercise/Conversion
Stock Option (right to buy)
2015-03-24−26,689→ 0 total
Exercise: $2.59Exp: 2017-10-04→ Common Stock (26,689 underlying)
Exercise/Conversion
Common Stock
2015-03-24$2.47/sh+52,985$130,873→ 1,562,301 total
Exercise/Conversion
Stock Option (right to buy)
2015-03-23−10,400→ 273,968 total
Exercise: $1.71Exp: 2015-08-03→ Common Stock (10,400 underlying)

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.65 to $11.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $11.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
[F3]This option is fully vested.

Documents

1 file